Literature DB >> 9576408

Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome.

J P Terdiman1, J W Ostroff.   

Abstract

PURPOSE: To determine the risk factors, etiology, and outcome of clinically important gastrointestinal bleeding that occurs after hospital admission (nosocomial gastrointestinal bleeding). PATIENTS AND METHODS: Cases consisted of consecutive patients who developed gastrointestinal bleeding more than 24 hours after admission to the hospital. Cases were compared with two control populations: a set of hospitalized patients without gastrointestinal bleeding matched with cases for age, gender, and length of stay; and all patients admitted to the hospital with clinically important gastroduodenal ulcer bleeding during the study period. Case and controls were compared with respect to risk factors for gastrointestinal bleeding and outcomes. Data were obtained through a comprehensive review of medical records.
RESULTS: Clinically important nosocomial gastrointestinal bleeding occurred in 67 inpatients after a mean hospital length of stay of 14 +/- 10 days. The majority (64%) of the patients were not hospitalized in the intensive care unit at the onset of the bleeding. Seventy-two percent of the patients who developed bleeding had been receiving some form of bleeding prophylaxis. In a multivariate analysis, a prior intensive care unit stay (odds ratio 2.5; 95% confidence interval 1.0 to 6.1; P <0.05) and mechanical ventilation (OR 3.4; 95% CI 1.1 to 10.7; P = 0.03) were independent risk factors for the onset of bleeding. Nosocomial gastrointestinal bleeding was associated with poor outcome, with an associated mortality of 34%. Duodenal ulcer disease was the most common source of nosocomial gastrointestinal bleeding, accounting for 36% of cases overall. Nosocomial ulcer bleeders were less likely to have a previous history of ulcer disease (13% versus 50%; P <0.05) Helicobacter pylori infection (14% versus 62%; P <0.0001), chronic active gastritis (29% versus 91%; P <0.0001), or to be taking NSAIDs (48% versus 68%; P <0.08) than patients admitted to the hospital with ulcer bleeding.
CONCLUSIONS: Gastrointestinal bleeding remains an important complication of hospitalization, with a high associated mortality. Our current approaches to prevention of this complication are imperfect. Bleeding tends to occur after a prolonged hospital stay and is more likely to occur in patients with more severe underlying illnesses. Duodenal ulcer disease is the most common source of this bleeding. Nosocomial gastroduodenal ulcer disease is distinct in etiology from the ulcer disease that occurs in outpatients.

Entities:  

Mesh:

Year:  1998        PMID: 9576408     DOI: 10.1016/s0002-9343(98)00055-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses.

Authors:  Hsiu-Chi Cheng; Ai-Wen Kao; Chiao-Hsiung Chuang; Bor-Shyang Sheu
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

2.  Risk factors of postoperative upper gastrointestinal bleeding following colorectal resections.

Authors:  Zhobin Moghadamyeghaneh; Steven D Mills; Alessio Pigazzi; Joseph C Carmichael; Michael J Stamos
Journal:  J Gastrointest Surg       Date:  2014-05-20       Impact factor: 3.452

3.  Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits.

Authors:  Hsiu-Chi Cheng; Bor-Shyang Sheu
Journal:  World J Gastrointest Endosc       Date:  2011-03-16

4.  Brief report: Reducing inappropriate usage of stress ulcer prophylaxis among internal medicine residents. A practice-based educational intervention.

Authors:  Joshua D Liberman; Chad T Whelan
Journal:  J Gen Intern Med       Date:  2006-05       Impact factor: 5.128

5.  Comparison of inpatient and outpatient upper gastrointestinal haemorrhage.

Authors:  Frank H Klebl; Nicole Bregenzer; Lars Schöfer; Wolfgang Tamme; Julia Langgartner; Jürgen Schölmerich; Helmut Messmann
Journal:  Int J Colorectal Dis       Date:  2004-11-13       Impact factor: 2.571

6.  Current Opinions on Stress-Related Mucosal Disease Prevention in Canadian Pediatric Intensive Care Units.

Authors:  Jérôme Ouellet; Dennis Bailey; Marie-Ève Samson
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

7.  Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis.

Authors:  Christophe Faisy; Emmanuel Guerot; Jean-Luc Diehl; Eléonore Iftimovici; Jean-Yves Fagon
Journal:  Intensive Care Med       Date:  2003-06-26       Impact factor: 17.440

Review 8.  Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disorders.

Authors:  Marc Bardou; Janet Martin; Alan Barkun
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Intravenous albumin shortens the duration of hospitalization for patients with hypoalbuminemia and bleeding peptic ulcers: a pilot study.

Authors:  Hsiu-Chi Cheng; Wei-Lun Chang; Wei-Ying Chen; Yu-Ching Tsai; Yi-Chun Yeh; Bor-Shyang Sheu
Journal:  Dig Dis Sci       Date:  2013-08-11       Impact factor: 3.199

10.  The Incidence and Mortality Impact of Gastrointestinal Bleeding in Hospitalized COVID-19 Patients.

Authors:  Jasbir Makker; Nikhitha Mantri; Harish K Patel; Hafsa Abbas; Ahmed Baiomi; Haozhe Sun; Yongsub Choi; Sridhar Chilimuri; Suresh Kumar Nayudu
Journal:  Clin Exp Gastroenterol       Date:  2021-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.